{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:32:55Z","timestamp":1791999175819,"version":"4.4.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T00:00:00Z","timestamp":1569456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006507","name":"Funda\u00e7\u00e3o Oswaldo Cruz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.02192","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T04:50:46Z","timestamp":1569473446000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Short-Lived Immunity After 17DD Yellow Fever Single Dose Indicates That Booster Vaccination May Be Required to Guarantee Protective Immunity in Children"],"prefix":"10.3389","volume":"10","author":[{"given":"Ana Carolina","family":"Campi-Azevedo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laise Rodrigues","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Peruhype-Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordana Grazziela","family":"Coelho-dos-Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lis Ribeiro","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Toscano","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Costa-Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine Maria","family":"Souza-Fagundes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismael Artur da","family":"Costa-Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Vaz de Melo","family":"Mambrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jandira Aparecida Campos","family":"Lemos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Geraldo Leite","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iramaya Rodrigues","family":"Caldas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Ant\u00f4nio Bastos","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria de Lourdes de Sousa","family":"Maia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana Guimar\u00e3es","family":"de Noronha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila Maria Barbosa","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisol","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos da Silva","family":"Freire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinaldo de Menezes","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Homma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Luiz","family":"Tauil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Fernando Costa","family":"Vasconcelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro Pecego Martins","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Magda","family":"Domingues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9a","family":"Teixeira-Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olindo Assis","family":"Martins-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,9,26]]},"reference":[{"key":"B1","unstructured":"Areas with Risk of Yellow fever Virus Transmission in Africa South America2019"},{"key":"B2","unstructured":"Yellow Fever Fact Sheet2019"},{"key":"B3","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S0140-6736(18)30152-1","article-title":"Yellow fever: a major threat to public health","volume":"391","year":"2018","journal-title":"Lancet"},{"key":"B4","unstructured":"Eliminate Yellow fever Epidemics (EYE): A Global Strategy 2017\u20132026.2017"},{"key":"B5","first-page":"269","article-title":"Vaccines and vaccination against yellow fever. WHO position paper \u2013 June 2013","volume":"88","year":"2013","journal-title":"Wkly Epidemiol Record"},{"key":"B6","article-title":"Background paper on yellow fever vaccine","volume-title":"Vaccine Position Papers","year":"2013"},{"key":"B7","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.1016\/j.vaccine.2014.07.021","article-title":"Duration of post-vaccination immunity against yellow fever in adults","volume":"32","author":"Caldas","year":"2014","journal-title":"Vaccine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1080\/21645515.2015.1082693","article-title":"Booster dose after 10 years is recommended following 17DD-YF primary vaccination","volume":"12","author":"Campi-Azevedo","year":"2016","journal-title":"Hum Vaccin Immunother."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e0006462","DOI":"10.1371\/journal.pntd.0006462","article-title":"Multi-parameter approach to evaluate the timing of memory status after primary 17DD-YF vaccination","volume":"12","author":"Costa-Pereira","year":"2018","journal-title":"PLoS Neglec Trop Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1590\/0074-02760170347","article-title":"Single shot of 17D vaccine may not confer life-long protection against yellow fever","volume":"113","author":"Vasconcelos","year":"2018","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"B11","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.tmaid.2013.08.007","article-title":"Yellow fever vaccination: is one dose always enough?","volume":"11","author":"Patel","year":"2013","journal-title":"Travel Med Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/1469-0691.12332","article-title":"Yellow fever revaccination guidelines change \u2013 a decision too feverish?","volume":"19","author":"Grobusch","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1080\/14760584.2016.1198259","article-title":"Questions regarding the safety and duration of immunity following live yellow fever vaccination","volume":"15","author":"Amanna","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"B14","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.bjm.2018.02.003","article-title":"Is a dose of 17D vaccine in the current context of Yellow Fever enough?","volume":"49","author":"Estofolete","year":"2018","journal-title":"Braz J Microbiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"6327","DOI":"10.1016\/j.vaccine.2011.05.019","article-title":"Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella","volume":"29","author":"Nascimento Silva","year":"2011","journal-title":"Vaccine"},{"key":"B16","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1046\/j.1365-3156.1999.00496.x","article-title":"Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA","volume":"4","author":"Niedrig","year":"1999","journal-title":"Trop Med Int Health"},{"key":"B17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/ni.1688","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans","volume":"10","author":"Querec","year":"2019","journal-title":"Nat Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/icb.2010.155","article-title":"Insights into human CD8(+) T-cell memory using the yellow fever and smallpox vaccines","volume":"89","author":"Ahmed","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jim.2017.05.002","article-title":"Heparin removal by ecteola-cellulose pre-treatment enables the use of plasma samples for accurate measurement of anti-Yellow fever virus neutralizing antibodies","volume":"448","author":"Campi-Azevedo","year":"2017","journal-title":"J Immunol Methods."},{"key":"B20","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.biologicals.2012.09.005","article-title":"Evaluation of accuracy and reliability of the plaque reduction neutralization test (micro-PRNT) in detection of yellow fever virus antibodies","volume":"40","author":"Sim\u00f5es","year":"2012","journal-title":"Biologicals."},{"key":"B21","first-page":"895","article-title":"Persistence of neutralizing antibody 30\u201335 years after immunization with 17D yellow fever vaccine","volume":"59","author":"Poland","year":"1981","journal-title":"Bull World Health Organ"},{"key":"B22","doi-asserted-by":"publisher","first-page":"434","DOI":"10.4269\/ajtmh.13-0264","article-title":"Review article: Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years","volume":"89","author":"Gotuzzo","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e0149871","DOI":"10.1371\/journal.pone.0149871","article-title":"A single 17D yellow fever vaccination provides lifelong immunity; characterization of yellow-fever-specific neutralizing antibody and T-cell responses after vaccination","volume":"11","author":"Wieten","year":"2016","journal-title":"PLoS One"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1172\/JCI75429","article-title":"Immune activation alters cellular and humoral responses to yellow fever 17D vaccine","volume":"124","author":"Muyanja","year":"2014","journal-title":"J Clin Invest"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1084\/jem.20082292","article-title":"Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses","volume":"205","author":"Gaucher","year":"2008","journal-title":"J Exp Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1016\/j.vaccine.2007.01.053","article-title":"Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213\/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program","volume":"25","year":"2007","journal-title":"Vaccine."},{"key":"B27","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1590\/0074-02760150176","article-title":"A randomized double-blind clinical trial of two yellow fever vaccines prepared with substrains 17DD and 17D-213\/77 in children nine-23 months old","volume":"110","year":"2015","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"B28","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/infdis\/jir439","article-title":"Cytokine signatures of innate and adaptive immunity in 17DD yellow fever vaccinated children and its association with the level of neutralizing antibody","volume":"204","author":"Luiza-Silva","year":"2011","journal-title":"J Infect Dis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1016\/j.vaccine.2005.12.055","article-title":"Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine","volume":"24","author":"Hepburn","year":"2006","journal-title":"Vaccine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41598-017-00798-1","article-title":"Adaptive immune responses to booster vaccination against yellow fever virus are much reduced compared to those after primary vaccination","volume":"7","author":"Kongsgaard","year":"2017","journal-title":"Sci Rep"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jtm\/tay108","article-title":"Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among US travellers","volume":"25","author":"Lindsey","year":"2018","journal-title":"J Travel Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.1016\/j.vaccine.2019.05.048","article-title":"Duration of immunity in recipients of two doses of 17DD yellow fever vaccine","volume":"37","year":"2019","journal-title":"Vaccine."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3201\/eid2508.181432","article-title":"17DD-Yellow Fever re-vaccination regimens are required for long-term persistence of neutralizing antibodies and memory CD8+ T-cells in populations of endemic areas with high risk of yellow fever transmission","volume":"25","author":"Campi-Azevedo","year":"2019","journal-title":"Emerg Infec Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e49828","DOI":"10.1371\/journal.pone.0049828","article-title":"17DD and 17D-213\/77 yellow fever substrains trigger a balanced cytokine profile in primary vaccinated children","volume":"7","author":"Campi-Azevedo","year":"2012","journal-title":"PLoS ONE"},{"key":"B35","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/(SICI)1096-9071(199810)56:2<159::AID-JMV10>3.0.CO;2-B","article-title":"Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection","volume":"56","author":"Reinhardt","year":"1998","journal-title":"J Med Virol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1038\/cti.2016.81","article-title":"Vaccination to gain humoral immune memory","volume":"5","author":"Sarkander","year":"2016","journal-title":"Clin Transl Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S1521-6616(03)00092-5","article-title":"Functional analysis of human memory B-cell subpopulations: IgD+CD27+ B cells are crucial in secondary immune response by producing high affinity IgM","volume":"108","author":"Shi","year":"2003","journal-title":"Clin Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02192\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T04:50:51Z","timestamp":1569473451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02192\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,26]]},"references-count":37,"alternative-id":["10.3389\/fimmu.2019.02192"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.02192","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,26]]},"article-number":"2192"}}